These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 2307980)

  • 1. Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study.
    Lee SC; Moore GR; Golenwsky G; Raine CS
    J Neuropathol Exp Neurol; 1990 Mar; 49(2):122-36. PubMed ID: 2307980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules.
    Lee SC; Raine CS
    J Neuroimmunol; 1989 Dec; 25(2-3):261-6. PubMed ID: 2479662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions.
    Bö L; Mörk S; Kong PA; Nyland H; Pardo CA; Trapp BD
    J Neuroimmunol; 1994 May; 51(2):135-46. PubMed ID: 8182113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
    Calderon TM; Eugenin EA; Lopez L; Kumar SS; Hesselgesser J; Raine CS; Berman JW
    J Neuroimmunol; 2006 Aug; 177(1-2):27-39. PubMed ID: 16782208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transgenic mice expressing polyoma virus large T antigen in astrocytes develop severe dysmyelination of the central nervous system.
    Baron-Van Evercooren A; Jensen NA; Wyss MT; Cuzin F; Rassoulzadegan M; Brucher JM; Baron H
    Lab Invest; 1992 Jan; 66(1):39-53. PubMed ID: 1309929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: relevance of class I and class II MHC-expressing cells to lesion development.
    Traugott U
    J Neuroimmunol; 1987 Oct; 16(2):283-302. PubMed ID: 3114324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
    Wolswijk G
    Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions.
    Traugott U; Lebon P
    J Neurol Sci; 1988 Apr; 84(2-3):257-64. PubMed ID: 3132537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.
    Henderson AP; Barnett MH; Parratt JD; Prineas JW
    Ann Neurol; 2009 Dec; 66(6):739-53. PubMed ID: 20035511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage function during Wallerian degeneration of rat optic nerve: clearance of degenerating myelin and Ia expression.
    Stoll G; Trapp BD; Griffin JW
    J Neurosci; 1989 Jul; 9(7):2327-35. PubMed ID: 2787393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial cell class II major histocompatibility complex molecule expression in stereotactic brain biopsies of patients with acute inflammatory/demyelinating conditions.
    van der Maesen K; Hinojoza JR; Sobel RA
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):346-58. PubMed ID: 10218630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of alpha B-crystallin to T cells in active multiple sclerosis lesions: an early event following inflammatory demyelination.
    Bajramović JJ; Plomp AC; Goes Av; Koevoets C; Newcombe J; Cuzner ML; van Noort JM
    J Immunol; 2000 Apr; 164(8):4359-66. PubMed ID: 10754336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrastructure of multiple sclerosis.
    Rodriguez M; Scheithauer B
    Ultrastruct Pathol; 1994; 18(1-2):3-13. PubMed ID: 8191643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis. Interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, nondemyelinating conditions.
    Wu E; Raine CS
    Lab Invest; 1992 Jul; 67(1):88-99. PubMed ID: 1625450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis: remyelination in acute lesions.
    Raine CS; Wu E
    J Neuropathol Exp Neurol; 1993 May; 52(3):199-204. PubMed ID: 7684075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages.
    Traugott U; Reinherz EL; Raine CS
    J Neuroimmunol; 1983 Jun; 4(3):201-21. PubMed ID: 6222066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis. Evidence for antigen presentation in situ by endothelial cells and astrocytes.
    Traugott U; Raine CS
    J Neurol Sci; 1985 Jul; 69(3):365-70. PubMed ID: 3897464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions.
    Itoyama Y; Webster HD; Richardson EP; Trapp BD
    Ann Neurol; 1983 Sep; 14(3):339-46. PubMed ID: 6195956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions.
    Höftberger R; Aboul-Enein F; Brueck W; Lucchinetti C; Rodriguez M; Schmidbauer M; Jellinger K; Lassmann H
    Brain Pathol; 2004 Jan; 14(1):43-50. PubMed ID: 14997936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of glial cell proliferation in early multiple sclerosis lesions.
    Schönrock LM; Kuhlmann T; Adler S; Bitsch A; Brück W
    Neuropathol Appl Neurobiol; 1998 Aug; 24(4):320-30. PubMed ID: 9775398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.